Form 4 Tracker
Nurix Therapeutics, Inc.
NRIX

42 insider filings · Latest: Oct 15, 2026

Common Stock Transactions
Txn DateAcceptedInsiderTypeSharesAvg PriceValueShares OwnedFiling
Feb 9, 2026Feb 10 12:47 AMChristine RingChief Legal Officer
Sale
14,261$16.66$237.6K42,749(D)

View →

Feb 9, 2026Feb 9 9:29 PMCHRISTINE RING
Proposed Sale
14,261$16.85$240.3K—

View →

Jan 30, 2026Jan 31 1:39 AMHoute Hans VanChief Financial Officer
Sale
3,661$16.60$60.8K45,427(D)

View →

Jan 30, 2026Jan 31 1:38 AMChristine RingChief Legal Officer
Sale
4,421$16.60$73.4K57,010(D)

View →

Jan 30, 2026Jan 31 1:36 AMGwenn HansenChief Scientific Officer
Sale
4,895$16.60$81.2K83,672(D)

View →

Jan 20, 2026Jan 21 12:57 AMChristine RingChief Legal Officer
Sale
3,760$18.42$69.3K50,897(D)

View →

Dec 18, 2025Dec 18 9:21 PMCHRISTINE RING
Proposed Sale
7,520$18.21$136.9K—

View →

Nov 24, 2025Nov 24 9:27 PMCHRISTINE RING
Proposed Sale
37,600$16.76$630.2K—

View →

Nov 3, 2025Nov 3 9:27 PMJOHANNES VAN HOUTE
Proposed Sale
6,284$12.94$81.3K—

View →

May 2, 2025May 2 8:22 PMJOHANNES VAN HOUTE
Proposed Sale
6,198$11.16$69.2K—

View →

Mar 3, 2025Mar 3 9:17 PMJOHANNES VAN HOUTE
Proposed Sale
5,825$15.45$90.0K—

View →

Jan 31, 2025Jan 31 9:33 PMCHRISTINE RING
Proposed Sale
5,760$20.02$115.3K—

View →

Jan 2, 2025Jan 2 9:20 PMCHRISTINE RING
Proposed Sale
5,760$18.84$108.5K—

View →

Dec 2, 2024Dec 2 9:36 PMCHRISTINE RING
Proposed Sale
5,760$22.11$127.4K—

View →

Nov 4, 2024Nov 4 9:29 PMCHRISTINE RING
Proposed Sale
3,290$24.47$80.5K—

View →

Nov 1, 2024Nov 1 8:50 PMJOHANNES VAN HOUTE
Proposed Sale
3,546$24.58$87.2K—

View →

Nov 1, 2024Nov 1 8:41 PMCHRISTINE RING
Proposed Sale
5,760$24.58$141.6K—

View →

Oct 1, 2024Oct 1 8:32 PMCHRISTINE RING
Proposed Sale
9,050$22.47$203.4K—

View →

Sep 3, 2024Sep 3 8:28 PMCHRISTINE RING
Proposed Sale
9,050$25.20$228.1K—

View →

Aug 26, 2024Aug 26 8:25 PMJOHANNES VAN HOUTE
Proposed Sale
20,000$24.02$480.4K—

View →

Stock Options & Derivatives
Txn DateAcceptedInsiderTypeSharesExercise PriceShares OwnedFiling
Oct 15, 2026Oct 15 9:00 PMGwenn HansenChief Scientific Officer
Option Exercise
1,452$1.8659,406(D)

View →

Oct 14, 2026Oct 14 8:11 PMJulia P GregoryDirector
Option Exercise
22,583$1.860(D)

View →

Oct 2, 2026Oct 2 9:21 PMChristine RingChief Legal Officer
Option Exercise
5,786$8.72111,251(D)

View →

Sep 2, 2026Sep 2 11:42 PMChristine RingChief Legal Officer
Option Exercise
5,787$8.72117,037(D)

View →

Sep 1, 2026Sep 1 9:19 PMGwenn HansenChief Scientific Officer
Option Exercise
1,452$1.8660,858(D)

View →

Aug 5, 2026Aug 5 10:59 PMGwenn HansenChief Scientific Officer
Option Exercise
4,356$1.8662,310(D)

View →

Aug 3, 2026Aug 3 9:51 PMChristine RingChief Legal Officer
Option Exercise
5,787$8.72122,824(D)

View →

Jul 30, 2026Jul 30 9:58 PMHoute Hans VanChief Financial Officer
Option Exercise
10,180—39,303(D)

View →

Jul 30, 2026Jul 30 9:56 PMChristine RingChief Legal Officer
Option Exercise
10,180—39,303(D)

View →

Jul 30, 2026Jul 30 9:50 PMGwenn HansenChief Scientific Officer
Option Exercise
10,180—39,303(D)

View →

Jul 2, 2026Jul 2 10:02 PMChristine RingChief Legal Officer
Option Exercise
11,008$8.72128,611(D)

View →

Jun 25, 2026Jun 25 10:38 PMChristine RingChief Legal Officer
Option Exercise
28,935$8.72134,398(D)

View →

Jun 2, 2026Jun 2 11:14 PMChristine RingChief Legal Officer
Option Exercise
3,422$1.865,221(D)

View →

May 15, 2026May 15 9:56 PMPaul M SilvaDirector
Grant/Award
31,250$15.8631,250(D)

View →

May 15, 2026May 15 9:55 PMEdward C SaltzmanDirector
Grant/Award
31,250$15.8631,250(D)

View →

May 15, 2026May 15 9:52 PMJudith A ReinsdorfDirector
Grant/Award
31,250$15.8631,250(D)

View →

May 15, 2026May 15 9:51 PMDavid L. LaceyDirector
Grant/Award
31,250$15.8631,250(D)

View →

May 15, 2026May 15 9:49 PMAnil KapurDirector
Grant/Award
31,250$15.8631,250(D)

View →

May 15, 2026May 15 9:46 PMRoger D DanseyDirector
Grant/Award
31,250$15.8631,250(D)

View →

May 15, 2026May 15 9:42 PMRoy D. BaynesDirector
Grant/Award
31,250$15.8631,250(D)

View →

Page 1 of 2

Next →